References
American Society of Health-System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172-1193.
Cavallo, D., Ursini, C. L., Perniconi, B., Di Francesco, A. D., Giglio, M., Rubino, F. M., … Iavicoli, S. (2005). Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutation Research, 587(1-2), 45-51. dx.doi.org/10.1016/j.mrgentox.2005.07.008
Connor, T. H., Anderson, R. W., Sessink, P. J., Broadfield, L., & Power, L. A. (1999). Surface contamination with antineoplastic agents in six cancer treatment centres in Canada and the United States. American Journal of Health-System Pharmacy, 56, 1427-1432.
Crass, R. E., & Vance, J. R. (1985). In vivo accuracy of gravity-flow i.v. infusion systems. American Journal of Hospital Pharmacy, 42, 328-331.
Crauste-Manciet, S., Sessink, P. J., Ferrari, S., Jomier, J. Y., & Brossard, D. (2005). Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Annals of Occupational Hygiene, 49, 619-628. dx.doi.org/10.1093/annhyg/mei045
Elad, D., Zaretsky, U., & Heller, O. (1994). Hydrodynamic evaluation of intravenous infusion systems. Annals of Emergency Medicine, 23, 457-463.
Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112-119. dx.doi.org/10.1097/01.ede.0000246827.44093.c1
Hedmer, M., Tinnerberg, H., Axmon, A., & Jönsson, B. A. (2008). Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. International Archives of Occupational and Environmental Health, 81, 899-911. dx.doi.org/1007/s00420-007-0284-y
International Society of Oncology Pharmacy Practicioners Standards Committee. (2007). ISOPP standards of practice. Safe handling of cytotoxics. Journal of Oncology Pharmacy Practice, 13(Suppl.) 1-81. dx.doi.org/10.1177/1078155207082350
Jochimsen, P. R. (1992). Handling of cytotoxic drugs by healthcare workers. A review of the risks of exposure. Drug Safety, 7, 374-380.
Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J., & Baxter, P. J. (2005). Exposure to antineoplastic drugs in two UK hospital pharmacy units. Annals of Occupational Hygiene, 49, 603-610. dx.doi.org/10.1093/annhyg/mei023
Mason, H. J., Morton, J., Garfitt, S. J., Iqbal, S., & Jones, K. (2003). Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Annals of Occupational Hygiene, 47, 681-685. dx.doi.org/10.1093/annhyg/meg078
Nygren, O., Gustavsson, B., Ström, L., Eriksson, R., Jarneborn, L., & Friberg, A. (2002). Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and a closed system. Journal of Environmental Monitoring, 4, 739-742. dx.doi.org/10.1039/b205132j
Nygren, O., Olofsson, E., & Johansson, L. (2008). Spill and leakage using a drug preparation system based on a double-filter technology. Annals of Occupational Hygiene, 52, 95-98. dx.doi.org/10.1093/annhyg/mem067
Occupational Safety and Health Administration. (1996). Controlling occupational exposure to hazardous drugs. American Journal of Health-System Pharmacy, 53, 1669-1685.
Pleasants, R. A., Sawyer, W. T., Williams, D. M., McKenna, W. R., Brown, J. M., & Powell, J. R. (1988). Accuracy of tobramycin delivery by four i.v. infusion methods. Clinical Pharmacy, 7, 367-373.
Pleasants, R. A., Sawyer, W. T., Williams, D. M., McKenna, W. R., & Powell, J. R. (1988). Effect of four intravenous infusion methods on tobramycin pharmacokinetics. Clinical Pharmacy, 7, 374-379.
Roberts, S., Khammo, N., McDonnell, G., & Sewell, G. J. (2006). Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations. Journal of Oncology Pharmacy Practice, 12, 95-104. dx.doi.org/10.1177/1078155206070439
Selevan, S. G., Lindbohm, M. L., Hornung, R. W., & Hemminki, K. (1985). A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313, 1173-1178. dx.doi.org/10.1056/NEJM198511073131901
Sessink, P. J., Friemèl, N. S., Anzion, R. B., & Bos, R. P. (1994). Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. International Archives of Occupational and Environmental Health, 65, 401-403. dx.doi.org/10.1007/BF00383251
Sessink, P. J., Rolf, M., & Ryden, N. S. (1999). Evaluation of the PhaSeal hazardous drugs containment system. Hospital Pharmacy, 34, 1311-1317.
Sessink, P. J., Timmersmans, J. L., Anzion, R. B., & Bos, R. P. (1994). Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. Determination of a-fluoro-b-alanine in urine. Journal of Occupational Medicine, 36, 79-83.
Sessink, P. J., van de Kerkhof, M. C., Anzion, R. B., Noordhoek, J., & Bos, R. P. (1994). Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route? Archives of Environmental Health, 49, 165-169. dx.doi.org/10.1080/00039896.1994.9940377
Simon, N., Décaudin, B., & Odou, P. (2008). Medical devices for the safe reconstitution of cytotoxics. European Journal of Hospital Pharmacy Practice, Fall, S25 S27.
Spivey, S., & Connor, T. H. (2003). Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hospital Pharmacy, 38(2), 135-139.
Valanis, B., Vollmer, W. M., & Steele, P. (1999). Occupational exposure to antineoplastic agents: Self-reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41, 632-638.
Vermeulen, R., Heideman, J., Bos, R. P., & Kromhout, H. (2000). Identification of dermal exposure pathways in the rubber manufacturing industry. Annals of Occupational Hygiene, 44, 533-541.
Ziegler, E., Mason, H. J., & Baxter, P. J. (2002). Occupational exposure to cytotoxic drugs in two UK oncology wards. Occupational and Environmental Medicine, 59, 608-612.
Ziser, M., Feezor, M., & Skolaut, M. W. (1979). Regulating intravenous fluid flow: Controller versus clamps. American Journal of Hospital Pharmacy, 36, 1090-1094.